Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103192064> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2103192064 endingPage "3530" @default.
- W2103192064 startingPage "3511" @default.
- W2103192064 abstract "Historically, patients with disseminated cancer have had poor prognoses and chemotherapy has been of little benefit. However, several different avenues of clinical research are providing reasons for hope. The advent of cytokine immunotherapy, particularly in combination with chemotherapy (biochemotherapy) has seen significantly improved outcomes for metastatic disease. Early biochemotherapy trials often revealed more than 20% complete responses. Unfortunately, Phase III trials have not confirmed earlier expectations for reasons that are not clear, but may reflect the inclusion of patients with refractory brain or other metastases in later trials. More recently, cancer vaccine therapies have provided significantly improved patient survival rates. It is not uncommon for 5-year survival rates of post-surgical patients recovering from metastatic malignancy who receive cancer vaccine therapy to reach more than 50%. Cytokines have become an integral part of cancer therapy and are also under trial together with cancer vaccines as post-surgical adjuvant therapies providing significant gains in long term survival rates. New insights from several different areas of research into the properties of tumour cells and their significance for immunosurveillance point to the importance of the tumour cells themselves as antigen presenting cells. Recent developments with genetically deficient animals and cancer cells have provided greater understanding at the molecular level of the importance of a functioning antigen presenting system operating inside tumour cells. This new knowledge offers support for further enhancing patient survival by combining previous therapies such as use of cytokines in biochemotherapy together with immunization using cytokine activated whole cell cancer vaccines in the future. Keywords: cytokines, immunotherapy, cancer vaccines, immune surveillance, patient survival, response rates" @default.
- W2103192064 created "2016-06-24" @default.
- W2103192064 creator A5006919697 @default.
- W2103192064 creator A5039133215 @default.
- W2103192064 creator A5082131007 @default.
- W2103192064 date "2005-10-01" @default.
- W2103192064 modified "2023-09-23" @default.
- W2103192064 title "Use of Cytokines in Cancer Vaccines/Immunotherapy: Recent Developments Improve Survival Rates for Patients with Metastatic Malignancy" @default.
- W2103192064 doi "https://doi.org/10.2174/138161205774414574" @default.
- W2103192064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16248805" @default.
- W2103192064 hasPublicationYear "2005" @default.
- W2103192064 type Work @default.
- W2103192064 sameAs 2103192064 @default.
- W2103192064 citedByCount "12" @default.
- W2103192064 countsByYear W21031920642015 @default.
- W2103192064 countsByYear W21031920642019 @default.
- W2103192064 crossrefType "journal-article" @default.
- W2103192064 hasAuthorship W2103192064A5006919697 @default.
- W2103192064 hasAuthorship W2103192064A5039133215 @default.
- W2103192064 hasAuthorship W2103192064A5082131007 @default.
- W2103192064 hasConcept C121608353 @default.
- W2103192064 hasConcept C126322002 @default.
- W2103192064 hasConcept C143998085 @default.
- W2103192064 hasConcept C203014093 @default.
- W2103192064 hasConcept C2776694085 @default.
- W2103192064 hasConcept C2776885095 @default.
- W2103192064 hasConcept C2777701055 @default.
- W2103192064 hasConcept C2777863537 @default.
- W2103192064 hasConcept C2778378633 @default.
- W2103192064 hasConcept C2778690821 @default.
- W2103192064 hasConcept C2779134260 @default.
- W2103192064 hasConcept C2779399171 @default.
- W2103192064 hasConcept C535046627 @default.
- W2103192064 hasConcept C71924100 @default.
- W2103192064 hasConceptScore W2103192064C121608353 @default.
- W2103192064 hasConceptScore W2103192064C126322002 @default.
- W2103192064 hasConceptScore W2103192064C143998085 @default.
- W2103192064 hasConceptScore W2103192064C203014093 @default.
- W2103192064 hasConceptScore W2103192064C2776694085 @default.
- W2103192064 hasConceptScore W2103192064C2776885095 @default.
- W2103192064 hasConceptScore W2103192064C2777701055 @default.
- W2103192064 hasConceptScore W2103192064C2777863537 @default.
- W2103192064 hasConceptScore W2103192064C2778378633 @default.
- W2103192064 hasConceptScore W2103192064C2778690821 @default.
- W2103192064 hasConceptScore W2103192064C2779134260 @default.
- W2103192064 hasConceptScore W2103192064C2779399171 @default.
- W2103192064 hasConceptScore W2103192064C535046627 @default.
- W2103192064 hasConceptScore W2103192064C71924100 @default.
- W2103192064 hasIssue "27" @default.
- W2103192064 hasLocation W21031920641 @default.
- W2103192064 hasLocation W21031920642 @default.
- W2103192064 hasOpenAccess W2103192064 @default.
- W2103192064 hasPrimaryLocation W21031920641 @default.
- W2103192064 hasRelatedWork W1973286952 @default.
- W2103192064 hasRelatedWork W1986962886 @default.
- W2103192064 hasRelatedWork W2008529945 @default.
- W2103192064 hasRelatedWork W2147248315 @default.
- W2103192064 hasRelatedWork W2408690724 @default.
- W2103192064 hasRelatedWork W2948610106 @default.
- W2103192064 hasRelatedWork W3029632585 @default.
- W2103192064 hasRelatedWork W3116716456 @default.
- W2103192064 hasRelatedWork W3136141307 @default.
- W2103192064 hasRelatedWork W3149203513 @default.
- W2103192064 hasVolume "11" @default.
- W2103192064 isParatext "false" @default.
- W2103192064 isRetracted "false" @default.
- W2103192064 magId "2103192064" @default.
- W2103192064 workType "article" @default.